Home > Financial Ratios > JAGSONPAL PHARMACEUTICALS

JAGSONPAL PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
AD     Remove this Ad

JAGSONPAL PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 83.21-18.9040.1821.22112.25

What is the latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of JAGSONPAL PHARMACEUTICALS is 83.21 based on Mar2025 Standalone results.
Year Core EBITDA Growth
Mar202583.21
Mar2024-18.90
Mar202340.18
Mar202221.22
Mar2021112.25

How is Core EBITDA Growth of JAGSONPAL PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 83.21
Positive
Mar2024 -18.9
Negative
Mar2023 40.18
89.35
Mar2022 21.22
-81.10
Mar2021 112.25 -

Other Financial Ratios of JAGSONPAL PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of JAGSONPAL PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS ₹1,172.8 Cr 1.1% 6.3% -24.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,753.0 Cr 1.5% 5.5% 0.5% Stock Analytics
DIVIS LABORATORIES ₹167,032.0 Cr 2.3% 3.6% 7.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹143,426.0 Cr -0.5% 5.3% 40.2% Stock Analytics
CIPLA ₹108,360.0 Cr -1.1% -2.2% -8.9% Stock Analytics
DR REDDYS LABORATORIES ₹106,859.0 Cr 0.9% 5.2% 7% Stock Analytics


JAGSONPAL PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
JAGSONPAL PHARMACEUTICALS

1.1%

6.3%

-24.4%

SENSEX

0.2%

1.1%

8.8%


You may also like the below Video Courses